Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12589055 | Dental composition | 🖼🧊📄§ | 2026-03-31 | 2040-09-10 | 0 | 31 |
| 12588863 | Systems and methods for preventing and treating wrinkles | 🖼🧊📄§ | 2026-03-31 | 2044-05-15 | 0 | 31 |
| 12588884 | Closed-loop elution system to evaluate patients with suspected or existing peripheral arterial disease | 🖼🧊📄§ | 2026-03-31 | 2042-06-10 | 0 | 31 |
| 12588675 | Synergistic antibacterial activity of medium polarity oils in combination with antibacterial agents on bacterial biofilms | 🖼🧊📄§ | 2026-03-31 | 2043-04-03 | 0 | 31 |
| 12588689 | Feed additive composition containing erythritol | 🖼🧊📄§ | 2026-03-31 | 2041-09-07 | 0 | 31 |
| 12590153 | Treatment of PD-L1-negative melanoma using an anti-PD-1 antibody and an anti-CTLA-4 antibody | 🖼🧊📄§ | 2026-03-31 | 2041-11-10 | 0 | 31 |
| 12589148 | Immunity-inducing agent comprising antigen peptide-adjuvant nucleotide conjugate and pharmaceutical composition comprising same | 🖼🧊📄§ | 2026-03-31 | 2039-09-27 | 0 | 31 |
| 12589189 | Use of retinoic acid receptor (RAR) agonists for reversing, preventing, or delaying calcification of aortic valve | 🖼🧊📄§ | 2026-03-31 | 2040-10-01 | 0 | 31 |
| 12589145 | Systems to produce B cells genetically modified to express selected antibodies | 🖼🧊📄§ | 2026-03-31 | 2043-02-08 | 0 | 31 |
| 12589168 | Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems | 🖼🧊📄§ | 2026-03-31 | 2042-04-29 | 0 | 31 |
| 12589077 | Method for preparing biodegradable microcapsules and microcapsules thus obtained | 🖼🧊📄§ | 2026-03-31 | 2041-11-18 | 0 | 31 |
| 12589134 | Compositions and methods of use of interleukin-10 in combination with immune check-point pathway inhibitors | 🖼🧊📄§ | 2026-03-31 | 2043-10-17 | 0 | 31 |
| 12589139 | Clostridial neurotoxins comprising an exogenous activation loop | 🖼🧊📄§ | 2026-03-31 | 2039-09-27 | 0 | 31 |
| 12590188 | Tri-block copolymers and nano-fibrous gelling microspheres including the same | 🖼🧊📄§ | 2026-03-31 | 2040-04-09 | 0 | 31 |
| 12589136 | Viral vectors comprising RDH12 coding regions and methods of treating retinal dystrophies | 🖼🧊📄§ | 2026-03-31 | 2042-08-09 | 0 | 31 |
| 12589374 | Method for making multiparticulates from a liquid feed employing a spinning disc sprayer | 🖼🧊📄§ | 2026-03-31 | 2041-06-15 | 0 | 31 |
| 12590286 | Method for preparing agent for prevention of hair loss and promotion of hair regrowth through fusion fermentation of lactic acid bacteria | 🖼🧊📄§ | 2026-03-31 | 2043-06-21 | 0 | 31 |
| 12590010 | Titanium oxide powder and method for manufacturing same | 🖼🧊📄§ | 2026-03-31 | 2040-05-13 | 0 | 31 |
| 12590331 | Methods of determining whether a subject has or is at risk of having a central serous chorioretinopathy | 🖼🧊📄§ | 2026-03-31 | 2041-03-10 | 0 | 31 |
| 12590304 | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use | 🖼🧊📄§ | 2026-03-31 | 2040-05-21 | 0 | 31 |
| 12590335 | Targeted measure of transcriptional activity related to hormone receptors | 🖼🧊📄§ | 2026-03-31 | 2043-06-21 | 0 | 31 |
| 12590308 | Compositions and methods for suppressing intracellular synthesis of the beta subunit of human chorionic gonadotropin | 🖼🧊📄§ | 2026-03-31 | 2045-02-20 | 0 | 31 |
| 12590288 | Method of treating an inflammatory disease by administering an agent which binds a surface receptor on a tuft cell that induces an ILC class 2 inflammatory response | 🖼🧊📄§ | 2026-03-31 | 2038-04-12 | 0 | 31 |
| 12590950 | Methods for predicting ER-mediated DNA damage | 🖼🧊📄§ | 2026-03-31 | 2040-10-12 | 0 | 31 |
| 12590309 | Reprogramming of lipid metabolism to inhibit T cell senescence and enhance tumor immunotherapy | 🖼🧊📄§ | 2026-03-31 | 2040-05-19 | 0 | 31 |
| 12589184 | Clinical dressing loaded with coffee extract | 🖼🧊📄§ | 2026-03-31 | 2045-06-18 | 0 | 31 |
| 12589125 | Yogurt for regulating intestinal tract, preparation method therefor, and use thereof | 🖼🧊📄§ | 2026-03-31 | 2043-02-27 | 0 | 31 |
| 12590168 | Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof | 🖼🧊📄§ | 2026-03-31 | 2044-01-23 | 0 | 31 |
| 12590123 | Compounds and methods for treating cancer, viral infections, and allergic conditions | 🖼🧊📄§ | 2026-03-31 | 2040-06-25 | 0 | 31 |
| 12590139 | MHC class II molecules and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-07-29 | 0 | 31 |
| 12590157 | Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments | 🖼🧊📄§ | 2026-03-31 | 2043-07-20 | 0 | 31 |
| 12589133 | Methods of downregulating CCL20 genes for treatment of traumatic brain injuries | 🖼🧊📄§ | 2026-03-31 | 2041-11-10 | 0 | 31 |
| 12590149 | Antibody and bispecific antibody targeting LAG-3 and use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-06-11 | 0 | 31 |
| 12589122 | Methods and compositions for treating infectious, autoimmune, and allergic disease | 🖼🧊📄§ | 2026-03-31 | 2039-11-05 | 0 | 31 |
| 12589115 | Haematopoietic stem cell treatment | 🖼🧊📄§ | 2026-03-31 | 2039-03-29 | 0 | 31 |
| 12589094 | Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4 | 🖼🧊📄§ | 2026-03-31 | 2044-02-28 | 0 | 31 |
| 12589113 | Preparation of a therapeutic composition for treating autoimmune diseases | 🖼🧊📄§ | 2026-03-31 | 2044-10-01 | 0 | 31 |
| 12589081 | Curcumin compositions for osteoarthritis and joint wellness | 🖼🧊📄§ | 2026-03-31 | 2040-12-02 | 0 | 31 |
| 12589101 | Cyclodextrin protein drug conjugates | 🖼🧊📄§ | 2026-03-31 | 2042-06-10 | 0 | 31 |
| 12589061 | Method for producing silica particles and their use in cosmetic compositions | 🖼🧊📄§ | 2026-03-31 | 2041-05-04 | 0 | 31 |
| 12589064 | Trolox-peptide conjugate and use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-05-06 | 0 | 31 |
| 12589164 | Protease-cleavable substrates and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2045-03-14 | 0 | 31 |
| 12589158 | GLP-1/GIP dual agonist, preparation method and use thereof | 🖼🧊📄§ | 2026-03-31 | 2044-03-12 | 0 | 31 |
| 12589067 | Composition and methods for activating cellular signaling genes in innate inflammatory pathways | 🖼🧊📄§ | 2026-03-31 | 2043-06-05 | 0 | 31 |
| 12589096 | Ruxolitinib formulation for reduction of itch in atopic dermatitis | 🖼🧊📄§ | 2026-03-31 | 2045-07-21 | 0 | 31 |
| 12590307 | Translation enhancing nucleic acid compounds: ASO coupled translation-upregulation 1 (ACT-UP1) and uses thereof | 🖼🧊📄§ | 2026-03-31 | 2045-02-14 | 0 | 31 |
| 12589114 | GABA agonists and antagonists affect differentiation of hematopoietic stem cells and megakaryocyte progenitors | 🖼🧊📄§ | 2026-03-31 | 2040-05-11 | 0 | 31 |
| 12590966 | Method for treating cancer | 🖼🧊📄§ | 2026-03-31 | 2040-11-03 | 0 | 31 |
| 12590170 | Recombinant human antibodies that inhibit the human tissue kallikrein 7 (KLK7) and their use against diseases that cause desquamation of the skin | 🖼🧊📄§ | 2026-03-31 | 2041-05-14 | 0 | 31 |
| 12590069 | Crystalline salts of a plasma kallikrein inhibitor | 🖼🧊📄§ | 2026-03-31 | 2045-08-28 | 0 | 31 |